Three startups have been selected to join Merck’s equity-free accelerator program for digital health startups in Nairobi, Kenya.
In no particular order, the three startup are described below:
Flare is an uber-like Transportation Network Company that makes ambulance more readily accessible in Nairobi.
Miti Health improves the supply chain of medication. Miti Health uses a technological infrastructure to optimize the inefficient supply chains of current owners of private chemist, from inventory management to quality certification.
GiftedMom deals with the serious problem of maternal and infant mortality in sub-Saharan Africa. It is an SMS- and voice-driven m-health platform that provide expectant mothers with info about healthcare and gives them the agency to plan and prepare for their pregnancy.
The startups will now join Merck’s three-month accelerator program at the Nairobi Garage, a fully serviced co-working space for startups, techies and entrepreneurs.
Among other things, the startups will receive an equity-free funding of US$15,000 as well as access to Merck’s global network of experts for ongoing coaching and mentoring.
Also, Uganda’s Matibabu, an app that’s able to diagnose malaria without blood sample, has been selected to join Merck’s Darmstadt accelerator.
Instead of a blood sample, Matibabu uses a phone’s camera to diagnose malaria. It can tell if a person has malaria by measuring light absorption when pressed to the fingertip.
Matibabu, alongside two other startups, will receive an equity-free funding of 25,000 Euros, regular coachings and office space at the Merck Innovation Center at the headquarters in Darmstadt, Germany.
Both acceleration programs attracted 200 applications from 47 countries.
Merck is a leading science and technology company in healthcare, life science and performance materials. It is committed to supporting healthy families, healthy communities and healthy economies in Africa.